SGMS2 and urinary bladder cancer: The lymphatic metastasis to the SLN was remarkably decreased by 70% in the CDL treated group when compared to the CL treated control group (Figure 6F right and 6H), indicating that CD11b+ TAM play crucial role in lymphatic metastasis of bladder cancer cells.